AGS細胞 
	
		年限:	54 years
	
	
		細胞形態:	上皮樣
	
	
		運輸方式:	凍存運輸
	
	
		是否是腫瘤細胞:	1
	
	
		物種來源:	人
	
	
		生長狀態:	貼壁生長
	
	
		器官來源:	胃
	
	
		數量:	大量
	
	
		ATCC Number:	CRL-1739?
	
	
		相關**:	其他**
	
	
		AGS細胞Designations:	AGS
	
	
		Depositors:	 SC Barranco
	
	
		Biosafety Level:	2
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	adherent
	
	
		Organism:	Homo sapiens
	
	
		Morphology:	epithelial
	
	
		
	
	
		Source:	Organ: stomach
	
	
		Disease: gastric adenocarcinoma
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. AGS細胞Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Isolation:	Isolation date: 1979
	
	
		Applications:	transfection host
	
	
		Tumorigenic:	Yes
	
	
		Cytogenetic Analysis:	This is a hyperdiploid human cell line. The modal chromosome number was 49, occurring in 60% of cells. The rate of polyploidy was 3.6%. Single copy each for der(8)t(1;8) (q12;p23), der(19)t(19;?) (q13.6;?), minute chromosome M3, and C-group-like M12 was seen in all cells. The origins of both M3 and M12 defied identification presently. The t(13q14q) occurred in some. Generally there were three copies for N20, and single copy for X, N8 and N18. Occasionally there were three copies for N14.
	
	
		Age:	54 years
	
	
		Gender:	female
	
	
		Ethnicity:	Caucasian
	
	
		Comments: AGS細胞The AGS cell line was derived from fragments of a tumor resected from a patient who had received no prior therapy. The cells have a plating efficiency of 34% in the medium below. The line was cured at the ATCC of a prior mycoplasma infection .Subsequently, AGS has been determined to be infected with Parainfluenza type 5 (PIV5 formerly known as SV5). [PubMed: 17509637]
	
	
		Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated F-12K Medium, Catalog No. 30-2004. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
	
	
		Temperature: 37.0°C
	
	
		Subculturing:	Protocol:
	
	
		Remove and discard culture medium.
	
	
		Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
	
	
		Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
	
	
		Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37?C to facilitate dispersal.
	
	
		Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
	
	
		Add appropriate aliquots of the cell suspension to new culture vessels.
	
	
		Incubate cultures at 37?C.
	
	
		
	
	
		Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended
	
	
		Medium Renewal: Every 2 to 3 days
	
	
		Preservation:	Freeze medium: AGS細胞Complete growth medium, 95%; DMSO, 5%
	
	
		Storage temperature: liquid nitrogen vapor phase
	
	
		Doubling Time:	20 hrs
	
	
		Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2004
	
	
		recommended serum:ATCC 30-2020
	
	
		References:	22748: Barranco SC, et al. Heterogeneous responses of an in vitro model of human stomach cancer to anticancer drugs. Invest. New Drugs 1: 117-127, 1983. PubMed: 6678861
	
	
		23044: Barranco SC, et al. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 43: 1703-1709, 1983. PubMed: 6831414
	
	
		32252: Rieder G, et al. Role of adherence in Interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect. Immun. 65: 3622-3630, 1997. PubMed: 9284128
	
	
		32464: Segal ED, et al. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl. Acad. Sci. USA 93: 1259-1264, 1996. PubMed: 8577751